Pacira BioSciences

Quarterly Financials

Values in thousands2026-03-312025-12-312025-09-302025-06-30
Revenue
$177,376
$196,873
$179,516
$181,099
Gross Profit
140,963
156,574
145,238
140,233
EBITDA
29,507
25,285
34,368
29,241
EBIT
8,176
3,943
13,177
1,919
Net Income
2,916
1,637
5,432
-4,847
Net Change In Cash
177,376
196,873
179,516
181,099
Free Cash Flow
22,956
43,471
56,964
9,315
Cash
144,306
158,545
147,589
300,484
Basic Shares
40,910
42,981
44,459
45,459

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$726,411
$700,966
$674,978
$666,823
Gross Profit
576,662
530,538
490,309
467,528
EBITDA
122,503
29,118
154,585
140,379
EBIT
31,480
-49,667
79,011
48,878
Net Income
7,034
-99,560
41,955
15,909
Net Change In Cash
726,411
700,966
674,978
666,823
Free Cash Flow
136,661
178,753
139,488
115,198
Cash
158,545
276,774
153,298
104,139
Basic Shares
45,042
46,245
51,979
46,538

Earnings Calls

QuarterEPS
2026-03-31
$0.60
2025-12-31
$0.57
2025-09-30
$0.70
2025-06-30
$0.74